Cited by 168Schizophrenia research and treatmentGenomics and Rare DiseasesGenomic variations and chromosomal abnormalities

Exome sequencing in schizophrenia-affected parent–offspring trios reveals risk conferred by protein-coding de novo mutations

Open access
Howrigan, Daniel P., Rose, Samuel A., Samocha, Kaitlin E., Fromer, Menachem, Cerrato, Felecia, Chen, Wei J., Churchhouse, Claire, Chambert, Kimberly +16 more·2020·Nature Neuroscience

Abstract

Protein-coding de novo mutations (DNMs) are significant risk factors in many neurodevelopmental disorders, whereas schizophrenia (SCZ) risk associated with DNMs has thus far been shown to be modest. We analyzed DNMs from 1,695 SCZ-affected trios and 1,077 published SCZ-affected trios to better understand the contribution to SCZ risk. Among 2,772 SCZ probands, exome-wide DNM burden remained modest. Gene set analyses revealed that SCZ DNMs were significantly concentrated in genes that were highly expressed in the brain, that were under strong evolutionary constraint and/or overlapped with genes identified in other neurodevelopmental disorders. No single gene surpassed exome-wide significance; however, 16 genes were recurrently hit by protein-truncating DNMs, corresponding to a 3.15-fold higher rate than the mutation model expectation (permuted 95% confidence interval: 1-10 genes; permuted P = 3 × 10-5). Overall, DNMs explain a small fraction of SCZ risk, and larger samples are needed to identify individual risk genes, as coding variation across many genes confers risk for SCZ in the population.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41593-019-0564-3

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Earlier sequencing studies established that ultra-rare and de novo mutations contribute to schizophrenia risk and found enrichment in neuronal genes and synaptic processes.

    “Earlier schizophrenia sequencing studies have established that ultra-rare and de novo mutations contribute to risk as a category, and have prioritized disease-relevant tissues and processes, specifically observing an enrichment in neuronal genes and synaptic processes9,11,19–23.”
  • URV analysis has had limited success in individual gene discovery for schizophrenia due to power limitations, with only SETD1A robustly associated.

    “However, the analysis of URVs has had limited success in delivering individual gene discovery in schizophrenia because of power limitations, with only a single gene, SETD1A, identified as robustly associated16,21.”
  • The SETD1A de novo PTV finding supports the earlier report that SETD1A is associated with both schizophrenia and broader neurodevelopmental disorders.

    “supporting an earlier report that described SETD1A as a gene associated with both schizophrenia and broader neurodevelopmental disorders21.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 53 · Cited by 168

Research works printed but not linked: 1

  1. [34]Karczewski KJFLCTG, Cummings BB; Alföldi J; Wang Q; Collins RL, Laricchia KM; Ganna A; Birnbaum DP; Gauthier Laura D, Brand Harrison, Solomonson Matthew, Watts Nicholas A, Rhodes Daniel, Singer-Berk Moriel, Seaby Eleanor G, Kosmicki Jack A, Walters Raymond K, Tashman Katherine, Farjoun Yossi, Banks Eric, Poterba Timothy, Wang Arcturus, Seed Cotton, Whiffin Nicola, Chong Jessica X, Samocha Kaitlin E, Pierce-Hoffman Emma, Zappala Zachary, O’Donnell-Luria Anne H, Minikel Eric Vallabh, Weisburd Ben, Lek Monkol, Ware James S, Vittal Christopher, Armean Irina M, Bergelson Louis, Cibulskis Kristian, Connolly Kristen M, Covarrubias Miguel, Donnelly Stacey, Ferriera Steven, Gabriel Stacey, Gentry Jeff, Gupta Namrata, Jeandet Thibault, Kaplan Diane, Llanwarne Christopher, Munshi Ruchi, Novod Sam, Petrillo Nikelle, Roazen David, Ruano-Rubio Valentin, Saltzman Andrea, Schleicher Molly, Soto Jose, Tibbetts Kathleen, Tolonen Charlotte, Wade Gordon, Talkowski Michael E, The Genome Aggregation Database Consortium, Neale Benjamin M, Daly Mark J, MacArthur Daniel G, Variation across 141,456 human exomes and genomes reveals the spectrum of loss-of-function intolerance across human protein-coding genes. BioRxiv, 2019.

Authors
Howrigan, D. P., Rose, S. A., Samocha, K. E., Fromer, M., Cerrato, F., Chen, W. J., Churchhouse, C., Chambert, K., Chandler, S. D., Daly, M. J., Dumont, A., Genovese, G., Hwu, H.-G., Laird, N., Kosmicki, J. A., Moran, J. L., Roe, C., Singh, T., Wang, S.-H., Faraone, S. V., Glatt, S. J., McCarroll, S. A., Tsuang, M., & Neale, B. M.
Affiliations
  • Broad Institute (US)
  • National Taiwan University (TW)
  • University of California San Diego (US)
  • Harvard University (US)
  • SUNY Upstate Medical University (US)
  • China Medical University (TW)
Corresponding author
  • Howrigan, Daniel P.
  • Neale, Benjamin M.
Venue
Nature Neuroscience
Published
2020-01-13
Volume
23
Issue
2
Pages
185-193
ISSN
  • 1097-6256 (ISSN-L)
  • 1546-1726
OpenAlex
W2998914148
Cited by
168
References
53
Citations by year
2026: 10 · 2025: 18 · 2024: 29 · 2023: 29 · 2022: 34 · 2021: 27 · 2020: 19 · 2019: 2
FWCI
20.61
Type
journal article
Language
en
Open access
Locations
  • Nature Neuroscience (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
  • Digital Access to Scholarship at Harvard (DASH) (Harvard University) (acceptedVersion)
  • eScholarship (California Digital Library) (submittedVersion)
Funders
  • U.S. Department of Health & Human Services | NIH | National Human Genome Research Institute (R01 HG006855)
  • U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (R01 MH077139, R01 MH085521, RC2 MH089905)
  • Broad Institute | Stanley Center for Psychiatric Research, Broad Institute
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomic variations and chromosomal abnormalities
Keywords
schizophrenia, de novo mutations, parent-offspring trios, exome sequencing, neurodevelopmental disorders, brain-expressed genes, negative selection, recurrent mutations, genetic risk
MeSH terms
Exome Sequencing, Adult, Child, Family, Female, Humans, Male, Mutation, Parents, Schizophrenia, Genetic Predisposition to Disease

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review